INTERVIEW: Inside Singapore's biomedical R&D strategy

06 Dec 2013

As a former military man, Dr Benjamin Seet is crystal clear on the task facing the biomedical research council (BMRC) of Singapore's Agency for Science, Technology and Research (A*STAR).

"Our focus is mission-oriented research with economic outcomes, and to grow the capabilities and reputation of Singapore as a hub...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

ProKidney Pins Hopes On Accelerated Approval For Rilparencel

09 Jul 2025

• By Alaric DeArment

After posting encouraging Phase II results, the company plans to meet with the US FDA about using data from an ongoing Phase III study for an accelerated approval.

Eolo Pharma Advances In Obesity With Thermogenesis Approach

04 Jul 2025

• By Aakash Babu

Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.

Protagonist Hopes To Come From Behind In Obesity With Oral Triple Agonist

01 Jul 2025

• By Jessica Merrill

The company announced plans to move an oral GLP-1/GIP/GCG receptor agonist peptide into clinical development for obesity in 2026.

Altimmune’s Phase IIb MASH Data Send Share Price Plunging

27 Jun 2025

• By Joseph Haas

Altimmune’s stock price did not recover on June 27, after a 57% dip the day before, despite efforts to position pemvidutide as both resolving MASH and offering weight loss.

AbbVie Licenses IGI’s ISB 2001 In Second Myeloma Trispecific Deal For 2025

10 Jul 2025

• By Alaric DeArment

IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.